President & Chief Executive Officer
Pamela Weir joined Precera Bioscience as President & Chief Executive Officer in January of 2018. Precera Bioscience is dedicated to Optimizing Medication Therapy by personalizing drug therapy practices and improving outcomes through cutting-edge science and a precise, patient-centric approach. Pamela has 30 years of pharmaceutical experience – innovating, building and transacting successful companies, divisions, product portfolios and global brands, based in the U.S., Europe and Canada. She has led functions in Commercial, R&D, Operations, Business Development and General Management. Pamela has extensive leadership and launch experience in global & U.S. markets, with primary care, hospital and specialty products in both retail and buy and bill distribution, across numerous therapeutic areas.